Jack Ma-Backed Pollon Life Is Said to File Confidentially for Hong Kong IPO

Pollon Life, a Chinese maker of stem cell drugs, has filed confidentially for a Hong Kong initial public offering that could raise about $300 million or more, according to people familiar with the matter.